Drug Type Colony-stimulating factors |
Synonyms GlycoPEG-GCSF, GlycoPEGylated G-CSF, GlycoPEGylated granulocyte colony-stimulating factor + [7] |
Target |
Action agonists |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date European Union (25 Jul 2013), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10242 | Lipegfilgrastim |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Febrile Neutropenia | European Union | 25 Jul 2013 | |
Febrile Neutropenia | Iceland | 25 Jul 2013 | |
Febrile Neutropenia | Liechtenstein | 25 Jul 2013 | |
Febrile Neutropenia | Norway | 25 Jul 2013 | |
Neutropenia | European Union | 25 Jul 2013 | |
Neutropenia | Iceland | 25 Jul 2013 | |
Neutropenia | Liechtenstein | 25 Jul 2013 | |
Neutropenia | Norway | 25 Jul 2013 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | Bulgaria | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | Czechia | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | Hungary | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | Poland | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | Russia | 01 Jul 2012 | |
Peripheral Primitive Neuroectodermal Tumors | Phase 1 | Ukraine | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | Bulgaria | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | Czechia | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | Hungary | 01 Jul 2012 | |
Rhabdomyosarcoma | Phase 1 | Poland | 01 Jul 2012 |
Not Applicable | 104 | Pegfilgrastim 6 mg | mozgybcvib(klbolvgnza) = svcghvvnsl eyaksogcfz (pofacuuzhb ) View more | - | 29 Aug 2020 | ||
mozgybcvib(klbolvgnza) = abrieyrvxy eyaksogcfz (pofacuuzhb ) View more | |||||||
Not Applicable | 328 | fucxamuyke(ocauloownr) = ibzcxulomx xybxzaoeog (nkdlwjwsey ) View more | - | 28 Sep 2019 | |||
Phase 1/2 | 24 | hvjwlucfrn(kxtwhmazsw) = 13% xktyurphzs (jdkuznnwlk ) View more | - | 15 Jun 2019 | |||
Not Applicable | - | embwoocvyh(msslbwtktq) = aqnntrpfjl vokljeozki (fkyhzezcxa ) View more | Positive | 22 Oct 2018 | |||
Not Applicable | 249 | qomacmzyyo(uwialxwvhl) = pmmyxczivk rbpzfalgbk (ehvdgzdymy ) View more | Positive | 18 May 2017 | |||
Phase 1 | 21 | chemotherapy+lipegfilgrastim | wwndtvvnvq(vyscpsncry) = 57% of patients; febrile neutropenia, leukopenia, neutropenia, and thrombocytopenia kqsmjsjetp (zyznjoxnkg ) | Positive | 01 Jan 2017 | ||
Not Applicable | - | bkhroqdcxt(afgrrdcklx) = ralaidrrxp ohnmtoehso (twskmjfcaw ) View more | Positive | 20 May 2012 | |||
Pegfilgrastim 6 mg | bkhroqdcxt(afgrrdcklx) = gbeerbxtpm ohnmtoehso (twskmjfcaw ) View more | ||||||
Not Applicable | 208 | lqlociwkbg(ktsbvqgihg) = wqnfopwzqd xotjqfkcil (crqojvjfdc ) | Positive | 20 May 2011 | |||
lqlociwkbg(ktsbvqgihg) = bqabuxcqkg xotjqfkcil (crqojvjfdc ) |